Regenotech Competitors

Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.

Biolife, a wholly owned subsidiary of Merit Medical, is medical device company in Sarasota, Florida, that manufactures innovative healthcare and first aid solutions that improve patient care and outcomes. All Biolife products are comprised of a powder with two main ingredients: potassium ferrate and a hydrophilic, or water loving, polymer. StatSeal devices for the healthcare industry are available in both powder and disc form; the disc is made of compressed powder that is encased in a white medical-grade foam. WoundSeal devices for the consumer and occupational health industries are available in powder form. All Biolife devices are manual pressure adjuncts and work via a two-step mechanism of action that occurs simultaneously to form a low pH seal or physical barrier over the wound, protecting it by letting nothing in or nothing out. The hydrophilic polymer rapidly dehydrates the blood and absorbs exudate, stacking up desiccated blood solids beneath to form a seal (scab). The potassium ferrate binds the blood solids and proteins together, adhering the seal (scab) to the wound to stop bleeding and oozing. Beneath the seal, the pH is neutral and blood solids and proteins continue to stack naturally. Above the seal the hydrophilic polymer acts as a desiccant and creates an acidic environment with a pH of ~ 2. All Biolife devices work independently of the clotting cascade to create an occlusive seal over the wound or procedural site, while accelerating hemostasis and helping to improve recovery time. The seal remains over the wound as the body’s healing mechanism begins. As the wound heals, the scab is naturally sloughed off.

Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.